Illustrative image – not actual.Mahindra & Mahindra is looking to make a fund infusion to the tune of KRW 450-500 billion (Rs 2,700 to 3,000 crore) to bring its South Korean subsidiary SsangYong Motor Company back to profitability by 2022.
SsangYong had registered its highest-ever yearly loss in 2019. The fund infusion is expected to be done through a combination of equity and bank loans.
SYMC posted a consolidated loss of around KRW 320 billion during 2019, which includes an asset write-down of around KRW 57 billion.
In addition to the finacial infusion, Mahindra & Mahindra plans to embark on material cost reduction to save KRW 80-90 billion per year.
Efforts to reduce capital expenditure without compromising on its product development, and bringing it in synergy with Mahindra & Mahindra is another focus area.
The company is also working on developing new overseas markets, including Russia and Vietnam, over the next two years to bolster its export volumes.
SsangYong had registered its highest-ever yearly loss in 2019. The fund infusion is expected to be done through a combination of equity and bank loans.
SYMC posted a consolidated loss of around KRW 320 billion during 2019, which includes an asset write-down of around KRW 57 billion.
In addition to the finacial infusion, Mahindra & Mahindra plans to embark on material cost reduction to save KRW 80-90 billion per year.
Efforts to reduce capital expenditure without compromising on its product development, and bringing it in synergy with Mahindra & Mahindra is another focus area.
The company is also working on developing new overseas markets, including Russia and Vietnam, over the next two years to bolster its export volumes.
